News

PRESENTS

NATIONAL PHARMACARE WEBINAR DEBATES

The biggest changes in over 30 years to drug regulations and drug plans in Canada will be implemented over the next year. Will your access to prescription drugs get better … or worse? Will the Ontario Conservative government’s rollback on OHIP+ (excluding kids with private drug coverage) affect a proposed National Pharmacare program? It’s up to you! Get informed to get involved.

The Canadian Organization for Rare Disorders invites you to learn more about the options for National Pharmacare. Follow this link to our survey to share your opinions. And stay tuned to sign up for our Webinar Pharmacare Debate Series.
Link to survey: https://www.surveymonkey.com/r/PatientsTalkPharmacare

PURPOSE

Engage patients and other stakeholders in informed deliberations on key issues that must be confronted in developing a National Pharmacare Programme, including global factors, defining principles, and optimal outcomes.

To read a description of each of the webinars, click here

TOPICS:

  1. DOES NATIONAL PHARMACARE MEAN SAME COVERAGE AND SAME PUBLIC PAYER FOR EVERYONE? (AUGUST 8)  RECORDING WEBINAR 1
  2. ORIGINAL AND SIMILAR BIOLOGIC DRUGS: LOW COST, INDIVIDUAL CHOICE, OR BOTH? (AUGUST 15)RECORDING WEBINAR 2
  3. HOW PMPRB REGULATES NEW DRUG PRICES: WILL CHANGES HELP OR HURT ACCESS? (AUGUST 29)RECORDING WEBINAR 3
  4. DRUGS FOR RARE DISEASES: NATIONAL PHARMACARE OR SEPARATE PROGRAM? (SEPTEMBER 27)RECORDING WEBINAR 4
  5. HOW CAN “RIGHT PRICING” SUPPORT INNOVATION AND COST-EFFECTIVE ACCESS? (OCTOBER 15) RECORDING WEBINAR 5
  6. BEYOND THE FORMULARY: SMART PHARMACARE FOR 21ST CENTURY THERAPIES (OCTOBER)

 

National Pharmacare Webinar Notice